T. Čabrijan

Molecular pathology of hemangiopericytomas accompanied by severe hypoglycemia: oncogenes, tumor-suppressor genes and the insulin-like growth factor family

K. Gall-Trošelj, K. Pavelić, R. Hrašćan, 1998, Journal of Cancer Research and Clinical Oncology.

The expression and role of insulin-like growth factor II in malignant hemangiopericytomas

K. Pavelić, T. Čabrijan, N. Karapandža, 1999, Journal of Molecular Medicine.

Insulin‐like growth factor family in malignant haemangiopericytomas: the expression and role of insulin‐like growth factor I receptor

K. Pavelić, Z. Pavelic, P. Stambrook, 1999, The Journal of pathology.

Autocrine tumour growth regulation by somatomedin C: an in-vitro model.

K. Pavelić, T. Čabrijan, S. Levanat, 1986, The Journal of endocrinology.

Multicentric clinical trial to assess efficacy and tolerability of acarbose (Bay G 5421) in comparison to glibenclamide and placebo

T. Čabrijan, Ž. Metelko, I. Kovačević, 1997 .

Molecular genetics of malignant insulinoma.

K. Pavelić, J. Gluckman, Z. Pavelic, 1996, Anticancer Research.

Multiple genetic alterations in malignant metastatic insulinomas

K. Pavelić, R. Hrašćan, B. Krušlin, 1995, The Journal of pathology.

Point mutation of tumor suppressor gene p53 in two highly malignant metastatic insulinomas

K. Pavelić, R. Hrašćan, T. Čabrijan, 2002 .

Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.

T. Čabrijan, J. Wyatt, Z. Milicevic, 2002, Medical science monitor : international medical journal of experimental and clinical research.

Autocrine tumour growth regulation by somatomedin C: An in — vitro model

K. Pavelić, T. Čabrijan, S. Levanat, 1987 .

The role of insulin-related substance in Hodgkin's disease

K. Pavelić, T. Čabrijan, J. Pavelić, 2005, Journal of Cancer Research and Clinical Oncology.